Li Ka Shing Institute of Health Sciences
2008- Present Professor, Department of Clinical Oncology, The Chinese University of Hong Kong 2004-2008 Associate Professor, Department of Clinical Oncology, The Chinese University of Hong Kong 1999-2004 Assistant Professor, Department of Oncology, Sidney Kimmel Cancer Center, Johns Hopkins Medicine, Baltimore; co-PI, Cancer Epigenetics Lab, Johns Hopkins Singapore 1995-1999 Postdoct, Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine 1991-1995 PhD, Department of Pathology, The University of Hong Kong Professional Societies: 2008-Present Vice-President, The Epigenetics Society 1994-Present International Association for Research on EBV and Associated Diseases American Association for Cancer Research (AACR)
Epigenetics, epigenomics, tumor suppressor gene, CpG methylation, carcinoma, cancer
Li LL, Zhang Y, Fan YC, Sun K, Su XW, Du ZF, Tsao SW, Loh TKS, Sun H, Chan ATC, Zeng YX, Chan WY, Chan FKL, Tao Q. Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes. Epigenomics 2015; 7: 155-173.